EBV the prototypical human tumor virus--just how bad is it?
about
Historical review of the causes of cancerRecent insights in the pathogenesis of post-transplantation lymphoproliferative disordersReplication of Epstein-Barr virus primary infection in human tonsil tissue explants.EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomasEBV-specific CD8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: activated phenotype and exhausted functionA new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.EBV in Hodgkin Lymphoma.The role of Epstein-Barr virus in cancer.Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 miceThe infectious kiss: newly infected B cells deliver Epstein-Barr virus to epithelial cellsIdentification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines.Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and resultsEBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cellsTherapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo.An auto-regulatory loop for EBV LMP2A involves activation of Notch.Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytesc-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancersThe impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients.Epidemiology: clues to the pathogenesis of Burkitt lymphoma.Epstein-Barr virus (EBV) microRNAs: involvement in cancer pathogenesis and immunopathology.Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?Multiple infections and cancer: implications in epidemiology.Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?Regulatory network analysis of Epstein-Barr virus identifies functional modules and hub genes involved in infectious mononucleosis.Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.Characterization of Epstein-Barr virus reactivation in a modeled spaceflight system.The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells.The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus.The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene.Nuclear-cytoplasmic shuttling is not required for the Epstein-Barr virus EBNA-LP transcriptional coactivation function.
P2860
Q26767036-EF4F6692-E5AD-47FD-9969-F4686F29EF00Q28075701-F51A1C7B-DF8E-47C6-A63C-5DFEE35A55C0Q31037038-0B5B89D4-45BD-4EEB-8A8F-055F05B8BB8DQ33739672-8B3BB8B6-DACA-4D42-BEAE-4CD13DAD4FAAQ33834491-BB5BDC89-D102-4359-867E-CC15AA71107AQ33851707-48A78C47-08C1-4DDD-88A4-19891842CF0EQ34079271-1958C340-2EF1-4661-B673-5922682EB94BQ34186560-3143A157-1447-4458-8027-0A8FF12F869AQ34457976-8DEDB393-779D-4C0C-A694-1FF6CB649607Q34549468-7199454E-B1D4-46EB-BE78-ADAA34574316Q34574840-0245FE74-590E-4901-A3A5-00D6DC2AF551Q34622693-057FE7A3-DB27-4976-8FC9-77E1551F3384Q34624363-A7577C71-ED39-4382-BB06-747CAFB1E562Q34985738-0A60139C-1E5E-41FF-A745-6AF0FA060666Q35115666-5781DE62-777F-4015-990B-5D757111A0D4Q35233147-FEF48156-D95D-4428-A819-0753A6ED318DQ35621627-AA0AF40A-3865-4ADE-85FC-221A8056D1C3Q35784734-A981934D-1607-4FEB-8C3E-9FDB68679FBBQ36241068-4CBD44DD-BC10-4AAF-8513-50A144393263Q36528115-A1B24FF1-B7FC-4541-92EB-7EA273F2968EQ36747670-94816048-49B0-49D5-8D0F-7939899938B5Q36979271-FB3F9CF5-0913-4688-B568-DF1C61731751Q37016499-52FE8E21-A4A8-4D4D-966F-D79912126749Q37112849-5565831E-3493-4273-8282-273F3AC03C75Q37192244-45FCFF50-CC12-4706-BD00-390A0DD2F243Q37272108-52B2621F-170B-431E-8C9E-B54235EBDB9FQ37362803-92A31281-6067-47FB-97EC-18255A1656C6Q37415188-14C46B64-A735-4357-8D7E-AED7DE4BD2F1Q37977130-4F2C5B4B-E1CB-44D5-BBC7-CB9587CDD37BQ38101668-3675AA5D-7E48-4215-ACFE-CB30149A6754Q38108302-DBA03A80-D59F-4AD6-AF74-C74F8F3BCBDEQ38126931-54CEF188-B642-407D-8B2D-1B56816ACBFEQ38186778-D9F8A9F3-51FB-4535-A919-F262DC71140AQ38437452-6C1DE188-CF91-415B-BC0C-A5A2A1210214Q38805572-038F80C3-2C98-40DF-9063-5530A41C645FQ39275909-C7A49228-71EC-4F09-AD9C-46B17E0F33F2Q39321358-0CFC4E84-8025-43D3-8F23-1000DEC7B3F2Q39559198-583A2034-1552-4693-9E55-DB62B82AA041Q39755299-49DD492F-F347-426E-A366-1C2A495A9C94Q39858749-BAAA31AC-7866-424F-97EE-C2A7599E314D
P2860
EBV the prototypical human tumor virus--just how bad is it?
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
EBV the prototypical human tumor virus--just how bad is it?
@ast
EBV the prototypical human tumor virus--just how bad is it?
@en
EBV the prototypical human tumor virus--just how bad is it?
@nl
type
label
EBV the prototypical human tumor virus--just how bad is it?
@ast
EBV the prototypical human tumor virus--just how bad is it?
@en
EBV the prototypical human tumor virus--just how bad is it?
@nl
prefLabel
EBV the prototypical human tumor virus--just how bad is it?
@ast
EBV the prototypical human tumor virus--just how bad is it?
@en
EBV the prototypical human tumor virus--just how bad is it?
@nl
P1476
EBV the prototypical human tumor virus--just how bad is it?
@en
P2093
David A Thorley-Lawson
P304
251-61; quiz 262
P356
10.1016/J.JACI.2005.05.038
P407
P577
2005-08-01T00:00:00Z